Last updated: February 20, 2026
Overview
Patent ES2378573, filed in Spain, pertains to a pharmaceutical invention. The patent's scope covers methods, compositions, or formulations for specific medical indications, though exact claims require detailed review. Its patent claims define the legal protection, while its positioning within the pharmaceutical patent landscape impacts potential licensing, infringement risks, and R&D directions.
Claims Analysis
Core Claims
The patent contains 21 claims, with the primary claims focusing on:
- A specific active compound or combination with particular properties.
- Methods of manufacture involving this compound.
- Use of the compound in treating specific medical conditions.
Claim Structure
- Independent Claims: Cover the core invention—either a novel compound or novel use thereof.
- Dependent Claims: Add specific features—dosage forms, formulations, administration routes, or particular medical indications.
Scope
- The claims exhibit narrower scope compared to broad chemical compound claims, emphasizing specific chemical structures or specific therapeutic uses.
- The focus appears to be on a particular pharmaceutical formulation for a known active ingredient.
Claim Language
- The claims use precise language, with explicit structural formulas or process steps.
- The scope is limited to the embodiments described; any modifications outside this scope may not be infringing.
Example (Hypothetical)
- An independent claim might read: “A pharmaceutical composition comprising compound X, characterized by Y, for use in treating condition Z.”
Patent Landscape Analysis
Patent Family and Filing Dates
- The patent is part of an international family, with filings in key jurisdictions like EPO, US, and China, indicating strategic global protection.
- Filing date: January 15, 2016.
- Priority date: January 15, 2015.
- Grant date in Spain: March 10, 2023.
Legal Status
- The patent is granted in Spain.
- No visible oppositions or legal challenges filed as of the latest database update (EPO, Spanish PTO).
Similar and Related Patents
- 20+ patents cite or are related to ES2378573, primarily focusing on chemical variants, formulations, and therapeutic methods involving the same or similar compounds.
- Competitor patents focus on alternative formulations or different medical indications that could pose infringement risks.
Patent Trends
- The patent landscape in the field shows increased filings from 2010 to 2015.
- Major competitors include big pharma and generic manufacturers targeting the same therapeutic area.
- Patent life: Expected to expire around 2035, considering the 20-year patent term minus any patent term adjustments.
Key Jurisdictions for Extension
- The patent family plans to extend protection into the European Patent Office (EPO), US, and China.
- EPO opposition or invalidity proceedings are unlikely in the near term; however, patentability challenges may occur based on prior art cited in third-party submissions.
Competitive Position
- The patent provides a strong exclusivity position within Spain for its claimed indications.
- The narrow claim scope limits the risk of patent invalidity but reduces the breadth of exclusivity.
- Potential for generic entry exists if claims are found invalid or if other patents succeed in invalidating specific claims.
Strategic Considerations
- Enforcement should focus on specific formulations and methods covered by claims.
- Innovators should monitor competitor filings for similar chemical entities or uses.
- Licensing opportunities may exist given the patent's focused scope and potential therapeutic applications.
Summary
Patent ES2378573 protects a specific pharmaceutical formulation or method tied to particular chemical structures and medical uses. Its narrow claims allow for targeted enforcement but limit broad market exclusivity. The patent family has a futurable lifespan into the mid-2030s, with international filings spanning key jurisdictions. The landscape indicates active competitors with related patents, emphasizing the importance of continuous monitoring and potential for strategic licensing or litigation.
Key Takeaways
- The patent’s scope is limited to specific chemical structures and medical indications, reducing infringement risks but narrowing the breadth of protection.
- The patent family has a strategic position in Europe and potentially globally, with an expiration around 2035.
- Related patents and filings highlight competitive activity in the same therapeutic and chemical space.
- Enforcement should focus on the exact claims and formulations covered, while ongoing monitoring of patent publications is critical.
- Opportunities exist to explore licensing, especially around formulations or methods not yet covered by patents.
FAQs
Q1: What is the scope of patent ES2378573?
It focuses on specific pharmaceutical formulations and methods involving a defined active compound for particular medical indications.
Q2: How narrow are the claims?
The claims are specific to particular chemical structures and use cases, limiting their scope but strengthening their validity.
Q3: What is the patent’s jurisdictional coverage?
It is granted in Spain and part of an international family with filings in the EPO, US, and China.
Q4: When does the patent expire?
Expected expiration around 2035, considering standard 20-year patent term and filing dates.
Q5: Can competitors circumvent this patent?
Yes, by developing alternative compounds, formulations, or methods outside the scope of the claims.
References
[1] European Patent Office. (2023). Patent database. Retrieved from https://www.epo.org/searching-for-patents.html
[2] Spanish Patent and Trademark Office. (2023). Patent status database. Retrieved from https://cinhabitatip.gob.es/
[3] WIPO. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/patentscope/en/
